Paracetamol Disrupts Early Embryonic Development Through Cell Cycle Inhibition
By
XzetaU8
Crisp on the outside, thoughtful on the inside. A keeper.
Summary
This scientific research article investigates the effects of paracetamol (acetaminophen) on early embryogenesis, specifically examining whether it interferes with cell division and disrupts preimplantation development. The study by researchers Brian S Nielsen and Morten R Petersen explores how paracetamol causes cell cycle inhibition during early embryonic development, potentially explaining its teratogenic effects.
Key quotes
· 2 pulledDoes paracetamol (N-acetyl-para-aminophenol (APAP) also known as acetaminophen) interfere with cell division and thereby disrupt preimplantation development
Paracetamol (N-acetyl-para-aminophenol) disrupts early embryogenesis by cell cycle inhibition
You might also wanna read
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·1h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·1h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·1h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·9h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·12h ago
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago